ZA90971B - Medicaments having controlled release of the active compound - Google Patents

Medicaments having controlled release of the active compound

Info

Publication number
ZA90971B
ZA90971B ZA90971A ZA90971A ZA90971B ZA 90971 B ZA90971 B ZA 90971B ZA 90971 A ZA90971 A ZA 90971A ZA 90971 A ZA90971 A ZA 90971A ZA 90971 B ZA90971 B ZA 90971B
Authority
ZA
South Africa
Prior art keywords
medicaments
active ingredient
active compound
controlled release
release
Prior art date
Application number
ZA90971A
Other languages
English (en)
Inventor
Manfred Buecheler
Buecheler Manfred
Andreas Ohm
Ohm Andreas
Roland Rupp
Rupp Roland
Josef Schmoll
Schmoll Josef
Axel Wollenschlaeger
Wollenschlaeger Axel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6373866&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA90971(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA90971B publication Critical patent/ZA90971B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA90971A 1989-02-11 1990-02-09 Medicaments having controlled release of the active compound ZA90971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3904093 1989-02-11

Publications (1)

Publication Number Publication Date
ZA90971B true ZA90971B (en) 1990-11-28

Family

ID=6373866

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90971A ZA90971B (en) 1989-02-11 1990-02-09 Medicaments having controlled release of the active compound

Country Status (15)

Country Link
US (1) US5204121A (xx)
EP (1) EP0386440B1 (xx)
JP (1) JPH02300126A (xx)
AT (1) ATE79029T1 (xx)
AU (1) AU622273B2 (xx)
CA (1) CA2009736A1 (xx)
DE (1) DE59000232D1 (xx)
DK (1) DK0386440T3 (xx)
ES (1) ES2044246T3 (xx)
GR (1) GR3005664T3 (xx)
HU (1) HU206044B (xx)
IE (1) IE900470L (xx)
IL (1) IL93315A0 (xx)
NZ (1) NZ232430A (xx)
ZA (1) ZA90971B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
DE4319760A1 (de) * 1993-06-15 1994-12-22 Bayer Ag Ipsapiron Arzneimittelzubereitung
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
US5532014A (en) * 1995-08-16 1996-07-02 Townsend Engineering Company Method of linking a strand of uncased coextruded meat emulsion product
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5843504A (en) * 1996-10-15 1998-12-01 Townsend Engineering Company Method and apparatus for coagulating the outer surface of a sausage strand discharged from a sausage extruding machine
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5938520A (en) * 1997-04-10 1999-08-17 Townsend Engineering Company Conveyor for supporting sausage strands during coagulation cycle, and method of rinsing and drying the same
JPH1147581A (ja) * 1997-07-30 1999-02-23 Takasago Internatl Corp 徐放性カプセル及びその製造方法
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7220430B2 (en) * 2000-01-27 2007-05-22 Tanabe Seiyaku Co., Ltd. Sustained-release preparation and process for producing the same
EP1323418B1 (en) 2000-09-06 2010-08-11 Mitsubishi Tanabe Pharma Corporation Granular preparations for oral administration
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
AUPR839001A0 (en) * 2001-10-19 2001-11-15 Eli Lilly And Company Dosage form, device and methods of treatment
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
MXPA04008100A (es) * 2002-02-21 2005-06-17 Biovail Lab Int Srl Formulaciones de liberacion modificada de al menos una forma de tramadol.
US6960346B2 (en) * 2002-05-09 2005-11-01 University Of Tennessee Research Foundation Vehicles for delivery of biologically active substances
WO2003097598A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Composé comprenant un antagonisme du récepteur de pdg2
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
US8193112B2 (en) * 2008-11-24 2012-06-05 University Of Lethbridge Catalysts for the polymerization of cyclic esters
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
MX2014013320A (es) 2012-05-07 2015-08-10 Bayer Pharma AG Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
CN112592311B (zh) * 2021-01-03 2023-01-31 迪沙药业集团有限公司 一种硝苯地平a晶块状晶习及其控释片组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
DE3769707D1 (de) * 1986-06-17 1991-06-06 Recordati Chem Pharm Therapeutisches system mit geregelter wirkstoffabgabe.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8703323D0 (en) 1987-02-13 1987-03-18 British Petroleum Co Plc Separation process
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒

Also Published As

Publication number Publication date
NZ232430A (en) 1991-10-25
HU900749D0 (en) 1990-04-28
HUT57585A (en) 1991-12-30
IL93315A0 (en) 1990-11-29
GR3005664T3 (xx) 1993-06-07
ES2044246T3 (es) 1994-01-01
AU4927090A (en) 1990-11-01
EP0386440B1 (de) 1992-08-05
CA2009736A1 (en) 1990-08-11
IE900470L (en) 1990-08-11
US5204121A (en) 1993-04-20
ATE79029T1 (de) 1992-08-15
EP0386440A1 (de) 1990-09-12
HU206044B (en) 1992-08-28
AU622273B2 (en) 1992-04-02
DE59000232D1 (de) 1992-09-10
DK0386440T3 (da) 1992-09-14
JPH02300126A (ja) 1990-12-12

Similar Documents

Publication Publication Date Title
ZA90971B (en) Medicaments having controlled release of the active compound
EP0235718A3 (en) Granule remaining in stomach
DK163208C (da) Retard-praeparat af acemetacin og fremgangsmaade til fremstilling deraf
HU9201623D0 (en) Pearl compositions covered with low solublity active agent
DE3874360D1 (de) Kugelfoermige granula mit kern sowie deren herstellung.
NZ235807A (en) Controlled release pellet formulation (core coated with or comprising a glucocorticosteroid, and a polymeric outer coating); capsules containing pellets; and use in treating bowel disease
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
GB8701813D0 (en) Projectile for use against passive and active armour
FI865227A (fi) Foerfarande foer framstaellning av ett depot-preparat.
EP0171528A3 (en) Controlled release pharmaceutical preparations
GB2223761B (en) Temporary protective aqueous coating composition
EP0616802A4 (en) PREPARATION ORALLY ADMINISTERED TO BE RELEASED IN THE LOWER DIGESTIVE TUBE.
GB2282967B (en) Composition containing fructose and plant extracts, for use in preventing and treating the after effects of excessive alcohol intake
HUT71740A (en) 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as insecticides
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
DE2963654D1 (en) 2-methylthio-4-cyclopropylamino-6-(alpha,beta-dimethylpropylamino)-s-triazine and the use of triazine derivatives as seewater algicides
EP0291872A3 (en) Wax-like compounds of aromatic alcohols, their preparation and application
DE3167136D1 (en) A photosensitive composition, an article comprising the composition and the use of the composition as a photoresist
EP0577699A4 (en) COMPOSITIONS AND METHODS INHIBITING ACTIVATION OF THE ACTIVE FACTOR XIII.
DE3267020D1 (en) Benzotriazoles, their preparation and use as medicines
DE69022251D1 (de) Niedrigdosiertes Aspirin mit gesteuerter Freigabe.
JPS5513252A (en) Preventive and remedy for swine dysentry
IL71165A0 (en) Ester of tricyclohexyltin hydroxide,its preparation and its use as insecticide and acaricide
EP0489933A4 (en) Bile alcohol and drug containing the same as active ingredient
JPS56135026A (en) Forming of slip resistance for bathtub, utility room or the like